Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)

Nagoya, Japan – The Japanese Association of Cancer Immunology (JACI) will host its 29th Annual Meeting from July 24th-26th, 2025, at WINC AICH, Nagoya, Japan. This marks the first time JACI will accept abstract submissions from international researchers, signifying a significant step towards global collaboration in cancer immunotherapy.

Conveniently located near JR Nagoya Station, attendees can easily explore Nagoya, Japan’s fourth-largest city and a historical hub dating back to the Edo era.

This year’s meeting focuses on advancing fundamental and translational cancer immunotherapy research. Highlights include:
* International Collaboration: JACI is actively seeking global partnerships. The meeting website and abstract submission process are available in English, welcoming researchers from around the world to participate in person or virtually.
* World-Renowned Speakers: Symposiums will feature leading international researchers, with dedicated time for panel discussions to foster interaction and collaboration.
* Joint Keynote Lectures: Collaborative keynote lectures will be delivered by experts from Japan and the US Society for Immunotherapy of Cancer.
* Cutting-Edge Topics: Symposiums will cover critical areas such as genetically modified immune cell therapies, spatial analysis, single-cell omics, and antibody-based cancer therapies.
* Educational Sessions: Six educational lectures will provide foundational knowledge for those new to cancer immunology.

Website: https://jaci2025.com/e